Anti-CD34 antibody, PA1334, Western blotting Lane 1: Recombinant Human CD34 Protein 10ng Lane 2: Recombinant Human CD34 Protein 5ng Lane 3: Recombinant Human CD34 Protein 2.5ng
Anti-CD34 Antibody Picoband(r)
PA1334
ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
ReactivityHamster, Human, Mouse, Rat
TargetCD34
Overview
- SupplierBoster Bio
- Product NameAnti-CD34 Antibody
- Delivery Days Customer9
- Antibody SpecificityNo cross reactivity with other proteins.
- Application Supplier NoteTested Species: In-house tested species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities. By Heat: Boiling the paraffin sections in 10mM citrate buffer, pH6.0, for 20mins is required for the staining of formalin/paraffin sections. Other applications have not been tested. Optimal dilutions should be determined by end users.
- ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
- Applications SupplierIHP, IHF, WB, IHC
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration500 ug/ml
- FormulationLyophilized
- Gene ID947
- Target nameCD34
- Target descriptionCD34 molecule
- Target synonymsCD34 antigen; hematopoietic progenitor cell antigen CD34
- HostRabbit
- IsotypeIgG
- Protein IDP28906
- Protein NameHematopoietic progenitor cell antigen CD34
- Scientific DescriptionBoster Bio Anti-CD34 Antibody catalog # PA1334. Tested in Flow Cytometry, IHC, IHC-F, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- ReactivityHamster, Human, Mouse, Rat
- Reactivity SupplierHuman, Mouse, Rat, Hamster
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203
References
- E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester). Xiong J et al., 2021, Int J NanomedicineRead more
- SIRT1 participates in the response to methylglyoxal-dependent glycative stress in mouse oocytes and ovary. Di Emidio G et al., 2019 Jun 1, Biochim Biophys Acta Mol Basis DisRead more
- Nanoparticles Based on Poly (beta-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy. Zhu D et al., 2018 Oct 3, Mol TherRead more
- Human nail stem cells are retained but hypofunctional during aging. Shi J et al., 2018 Jun, J Mol HistolRead more
- Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer. Zhang J et al., 2018 Jan 5, OncotargetRead more
- Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase. Zhang Y et al., 2016 Jun 28, OncotargetRead more
- Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device. Shi H et al., 2015, Cell CycleRead more
- Ultrastructure damage of oviduct telocytes in rat model of acute salpingitis. Yang J et al., 2015 Jul, J Cell Mol MedRead more
- Correlation between TSP-1, TGF-beta and PPAR-gamma expression levels and glioma microvascular density. Zhang J et al., 2014 Jan, Oncol LettRead more
- Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer. Shan X et al., 2013 Jan-Feb, J Comput Assist TomogrRead more